BRIEF-EMA says patients treated with direct-acting antivirals for hepatitis C may be at risk of hepatitis B re-activation
December 02, 2016 at 10:06 AM EST
* Patients treated with direct-acting antivirals for hepatitis C may be at risk of hepatitis B re-activation